Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Holis A. Holik"'
Autor:
Hendris Wongso, Isa Mahendra, Wyanda Arnafia, Idar Idar, Muhammad Yusuf, Arifudin Achmad, Holis A. Holik, Ahmad Kurniawan, Iim Halimah, Maula E. Sriyani, Teguh H. A. Wibawa, Muhamad B. Febrian, Yanuar Setiadi, Eva M. Widyasari, Isti Daruwati, Crhisterra E. Kusumaningrum, Toto Subroto
Publikováno v:
Vaccines, Vol 10, Iss 1, p 128 (2022)
The coronavirus disease 2019 (COVID-19) has become a substantial threat to the international health sector and the global economy. As of 26 December 2021, the number of mortalities resulting from COVID-19 exceeded 5.3 million worldwide. The absence o
Externí odkaz:
https://doaj.org/article/13bc2437628341c48fc15b9d2f4336fc
Publikováno v:
Jurnal Pengabdian Kepada Masyarakat (Indonesian Journal of Community Engagement), Vol 8, Iss 1, Pp 35-39 (2022)
Most breast cancer patients in Indonesia experienced a delay in their diagnosis due to a lack of awareness and other factors. Female adolescents are the key population for an educational intervention to raise breast cancer awareness. This study asses
Externí odkaz:
https://doaj.org/article/b5275dcf8e0f4ea4a4f468f94599b17c
Autor:
Holis Abdul Holik, Faisal Maulana Ibrahim, Angela Alysia Elaine, Bernap Dwi Putra, Arifudin Achmad, Achmad Hussein Sundawa Kartamihardja
Publikováno v:
Molecules, Vol 27, Iss 10, p 3062 (2022)
Therapeutic radiopharmaceuticals have been researched extensively in the last decade as a result of the growing research interest in personalized medicine to improve diagnostic accuracy and intensify intensive therapy while limiting side effects. Rad
Externí odkaz:
https://doaj.org/article/7fac186a711d47efbf86a5cd49e4ae89
Publikováno v:
Journal of Community Development. 3:318-324
Diabetes mellitus in Indonesia now ranks 5th with the highest number of diabetes mellitus sufferers in the world. At present, the prevalence has increased from 6.2% compared to 2019. Diabetics need to get effective and safe drugs in order to avoid va
Publikováno v:
International Journal of Applied Pharmaceutics. :111-115
Objective: In this study, an in silico test of 13 active compounds of leaf Jatropha multifida Linn. was carried out against the gyrase receptor (PDB ID: 2XCT). Methods: The methods include molecular docking, ADMET prediction, and a review of Lipinski
Autor:
HOLIS ABDUL HOLIK, LEVINA ARISTAWIDYA
Publikováno v:
International Journal of Applied Pharmaceutics. :33-37
This review was conducted to review the recent development of radionuclides that potentially used in diagnosis and therapy of lung cancer. A comprehensive article search used a systematic review method based on Preferred Reporting Items for Systemati
Autor:
FAISAL MAULANA IBRAHIM, HOLIS ABDUL HOLIK, GHIFARI FARHAN HASIBUAN, ACHMAD HUSSEIN SUNDAWA KARTAMIHARDJA
Publikováno v:
International Journal of Applied Pharmaceutics. :171-175
Objective: This in silico study aims to determine the inhibition effect of 5-BOTP with various bifunctional chelating agents (BFCA); NOTA, DOTA, TETA, CTPA, H2CB-DO2A, H2CBTE2A against the antiporter site of the LAT1. Methods: The research method con
Autor:
IKE SUSANTI, HOLIS ABDUL HOLIK
Publikováno v:
International Journal of Applied Pharmaceutics. :59-68
This review aimed to inform about the magnetic nanoparticle functionalization and solid magnetic phase extraction application to separate analytes in various types of samples. The review was conducted by analyzing several articles published in 2010 u
Autor:
HOLIS ABDUL HOLIK, FAISAL MAULANA IBRAHIM, ELISHA WIANATALIE, ARIFUDIN ACHMAD, AHMAD FARIED, ACHMAD HUSSEIN SUNDAWA KARTAMIHARDJA
Publikováno v:
International Journal of Applied Pharmaceutics. :205-209
Objective: In this study, various types of pharmacokinetic modifying linkers and chelators are combined with JPH203 to obtain the best-docked molecule for prospective radiopharmaceutical kits. Methods: AutoDock 4.2.6 and AutoDockTools 1.5.6 programs
Autor:
HOLIS ABDUL HOLIK, FAISAL MAULANA IBRAHIM, ABIB LATIFU FATAH, ARIFUDIN ACHMAD, ACHMAD HUSSEIN SUNDAWA KARTAMIHARDJA
Publikováno v:
International Journal of Applied Pharmaceutics. :239-243
Objective: This study aims to obtain a good activity of radiotheranostic kit for cancer which is built by combining (S)-2-amino-4-(3,5-dichlorophenyl) butanoic acid (ADPB) with various bifunctional chelators. Methods: This study was conducted through